Early Inhibition of Glycosylation with Deoxynojirimycin Has No Effect on the Replication of Flavivirus West Nile
スポンサーリンク
概要
- 論文の詳細を見る
Deoxynojirimycin (dNM) is a specific and reversible inhibitor of the trimming actions of glucosidase I and II in the rough endoplasmic reticulum. The importance of the effects of dNM on the replication of West Nile (sarafend-glycosylated) and West Nile (Wengler-nonglycosylated) viruses were studied. It was found that dNM treatment increase the molecular weights of the E and prM proteins in both virus strains without affecting the yields of the virus. The intracellular transport of the E protein from the rough endoplasmic reticulum to Golgi apparatus was not affected despite the change in molecular weights. It would appear that the prevention of removal of glucose molecules by dNM did not affected the maturation of E protein or the virus.
- 長崎大学熱帯医学研究所の論文
- 1994-06-30
長崎大学熱帯医学研究所 | 論文
- あらためて物理的バリアーを考える (第2部 研究集会) -- (感染症制圧をめざしたベンチャービジネス)
- HIV感染症の変貌とその対策
- ミニブタを用いたヒト住血吸虫症モデルの確立と応用
- 熱帯感染症に対する宿主感受性を決定する遺伝子多型の解析
- シャーガス病の病態に関する免疫遺伝学的研究